Sofinnova Partners Secures €1.2 Billion to Empower Next-Gen Life Sciences Innovations

Sofinnova Partners is excited to announce a major milestone with the successful raising of €1.2 billion in our latest funding round. As a leading European venture capital firm deeply rooted in life sciences, healthcare, and sustainability, this latest achievement further cements our long-standing reputation as one of the most trusted and visionary institutions within the industry. With headquarters in Paris, London, and Milan, our team of internationally acclaimed professionals – bringing together expertise in scientific research, medicine, and business development – is uniquely positioned to identify and nurture transformative innovations. Since our founding in 1972, Sofinnova Partners has established a legacy of nurturing over 500 companies and creating global market leaders, all underpinned by our hands-on approach that spans the entire investment life cycle, from seed to later-stage funding. The newly secured funding will accelerate our commitment to partnering with ambitious entrepreneurs and pioneering technologies. In a rapidly evolving landscape, these resources will not only support breakthrough advancements in the life sciences arena but will also empower startups to tackle some of the most pressing challenges facing global healthcare and sustainability. This financial boost comes at a pivotal time as we further extend our reach and deepen our impact, reinforcing our strategy to drive market transformation and improve lives around the world. With over €2.8 billion already under management, this injection of capital enhances our ability to support cutting-edge research and innovative business models that promise a positive impact on society. For more information about our vision and initiatives, please visit www.sofinnovapartners.com.